Home/ Supplements/ Vitamin K/ Low-Dose Vitamin K2 45 mcg

Low-Dose Vitamin K2 45 mcg

product on market Softgel Capsule Life Extension Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 supports calcium homeostasis by directing minerals toward bone formation and away from vascular tissues. There is moderate research evidence suggesting its role in maintaining bone density and cardiovascular health. This low-dose formulation is generally well-tolerated with a high safety profile.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Low-Dose Vitamin K2 45 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

45 mcg (56% DV)
Within RDA (0.4× RDA) 275 studies (A:9, B:175)

Other Ingredients

Medium Chain Triglycerides Gelatin Glycerin purified Water Beeswax Carob color Olive Oil Sunflower Oil
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Read the entire label and follow the directions carefully prior to use. Directions: Take one (1) softgel daily with food, or as recommended by a healthcare practitioner.

Warnings & Precautions

CAUTION: If you are taking anti-coagulant or anti-platelet medications, or have a bleeding disorder, consult your healthcare provider before taking this product.

-DO NOT EXCEED RECOMMENDED DOSE. -Do not purchase if outer seal is broken or damaged.

-When using nutritional supplement, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.

Contains soybeans.

Formulation Notes

Menaquinone-7 (MK-7)

Contains soybeans.

Non-GMO

Additional Information

Scan for product info

Store tightly closed in a cool, dry place.

Q01225G

Promotes Arterial Health and Healthy Bones*

To report a serious adverse event or obtain product information, contact 1-866-280-2852.

Metadata

Product Details

UPC / SKU7 37870 12259 3
DSLD Entry Date2016-04-22
Product TypeVitamin
FormSoftgel Capsule
BrandLife Extension
DSLD ID58957
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

Vitamin K-2
GNC Preventive Nutrition · Softgel Capsule
100
Vitamin K-2
NewtonEverett · Softgel Capsule
100
Natural Vitamin K-2 Bioactive Form
Vitamin World · Softgel Capsule
100
Vitamin K2 50 mcg
Vitacost · Softgel Capsule
100
Vitamin K2 45 mcg
Nutri-Rich · Softgel Capsule
100
View all Vitamin K products →
Vitamin K research Best Vitamin K All Vitamin K products More from Life Extension View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.